Skip to main content
. 2020 Jul 8;19:109. doi: 10.1186/s12933-020-01074-9

Table 3.

Logistic regression analysis of AG between plaque rupture and erosion with or without DM history

Exposure NDM history DM history Total
Crude
 Continuous HbA1c 1.62 (0.87, 3.02) 0.1303 1.04 (0.84, 1.30) 0.6970 1.10 (0.89, 1.36) 0.3874
 Continuous ARPG 1.11 (1.02, 1.21) 0.0182 1.04 (0.96, 1.12) 0.3539 1.07 (1.01, 1.14) 0.0213
 Continuous PFPG 1.04 (0.94, 1.14) 0.4550 0.96 (0.89, 1.05) 0.3658 0.99 (0.93, 1.06) 0.8630
 Continuous A/C 1.56 (0.80, 3.08) 0.1930 1.36 (0.57, 3.28) 0.4880 1.59 (0.57, 3.28) 0.0860
GVT
 Normal 1
 Up 2.79 (1.40, 5.55) 0.0030 1
 Down 2.54 (1.38, 4.67) 0.0030 1.32 (0.67, 2.59) 0.4170
Stratified ARPG
 < 6.1 1 1 1
 ≥ 6.1, < 7.0 1.53 (0.91, 2.59) 0.1107 1.41 (0.84, 2.37) 0.1909
 ≥ 7.0, < 11.1 2.14 (1.36, 3.38) 0.0011 2.07 (1.32, 3.24) 0.0014
 ≥ 11.1 1.96 (0.93, 4.15) 0.0781 2.29 (1.24, 4.21) 0.0080
Stratified PFPG
 < 5.6 1 1 1
 ≥ 5.6, < 6.1 0.86 (0.50, 1.51) 0.6089 0.92 (0.53, 1.59) 0.7621
 ≥ 6.1, < 7.0 1.06 (0.62, 1.80) 0.8403 0.40 (0.03, 5.15) 0.4822 1.00 (0.60, 1.68) 0.9981
 ≥ 7.0 1.25 (0.77, 2.01) 0.3685 0.78 (0.09, 6.87) 0.8232 1.20 (0.76, 1.90) 0.4250
Adjust I
 Continuous ARPG 1.07 (0.97, 1.18) 0.1528 1.06 (0.98, 1.16) 0.1609 1.06 (1.00, 1.13) 0.0710
 Stratified ARPG
  < 6.1 1 1 1
  ≥ 6.1, < 7.0 1.38 (0.77, 2.45) 0.2756 1.25 (0.71, 2.20) 0.4396
  ≥ 7.0, < 11.1 1.72 (1.04, 2.85) 0.0347 1.63 (1.00, 2.67) 0.0517
  ≥ 11.1 1.58 (0.70, 3.60) 0.2709 2.05 (1.05, 3.99) 0.0345
 GVT
  Normal 1
  Up 2.12 (1.02, 4.41) 0.0450
  Down 1.95 (1.03, 3.69) 0.0410
Adjust II
 Continuous ARPG 1.07 (0.98, 1.18) 0.1408 1.05 (0.96, 1.15) 0.2630 1.05 (0.99, 1.12) 0.0983
 Stratified ARPG
  < 6.1 1 1 1
  ≥ 6.1, < 7.0 1.29 (0.72, 2.33) 0.3920 1.17 (0.66, 2.08) 0.5945
  ≥ 7.0, < 11.1 1.67 (1.00, 2.80) 0.0514 1.58 (0.96, 2.61) 0.0736
  ≥ 11.1 1.67 (0.72, 3.85) 0.2313 1.99 (1.02, 3.90) 0.0438
 GVT
  Normal 1
  Up 2.16 (1.03, 4.55) 0.0420
  Down 1.89 (0.99, 3.60) 0.0550

Data are presented as OR (95% CI) P value. Adjustment I for: age; gender; HTN history; current smoking; LDL-C. Adjustment II for: age; gender; HTN history; current smoking; LDL-C; initial TIMI flow; multivessel lesion, and culprit vessel

A/C admission/chronic plasma glucose, ARPG admission random plasma glucose, DM diabetes mellitus, GVT glucose variable tendency, HbA1c glycosylated hemoglobin, HTN hypertension, LDL-C low density lipoprotein cholesterol, NDM nondiabetic mellitus, PCI percutaneous coronary intervention, PFPG post-PCI fasting plasma glucose, TIMI thrombolysis in myocardial infarction